Want to see VOR full AI Analyst Report?
Compare Vor Biopharma (VOR) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| VORVor Biopharma | $19.68 | $1.16B | 0.07 | -21.28% | Strong Buy | VOR | ||||
| CDXSCodexis | $1.19 | $130.31M | -3.54 | -49.58% | Strong Buy | VOR vs CDXS | ||||
| BDTXBlack Diamond Therapeutics | $1.78 | $102.27M | -2.40 | -53.40% | Strong Buy | VOR vs BDTX | ||||
| AVIRAtea Pharmaceuticals | $4.11 | $329.64M | -1.98 | 25.69% | Moderate Buy | VOR vs AVIR | ||||
| CRBUCaribou Biosciences | $0.42 | $45.37M | -0.39 | -81.77% | Moderate Buy | VOR vs CRBU | ||||
| KYTXKyverna Therapeutics, Inc. | $5.67 | $350.65M | -1.93 | -16.00% | Strong Buy | VOR vs KYTX |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| VOR | Vor Biopharma | 19.68 | -2.73 | -12.18% | |
| CDXS | Codexis | 1.19 | -1.07 | -47.35% | |
| BDTX | Black Diamond Therapeutics | 1.78 | -2.17 | -54.94% | |
| AVIR | Atea Pharmaceuticals | 4.11 | 0.86 | 26.46% | |
| CRBU | Caribou Biosciences | 0.42 | -2.01 | -82.59% | |
| KYTX | Kyverna Therapeutics, Inc. | 5.67 | -1.21 | -17.59% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts